Balapiravir hydrochloride
Modify Date: 2024-01-10 18:15:11
Balapiravir hydrochloride structure
|
Common Name | Balapiravir hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 690270-65-6 | Molecular Weight | 530.95900 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H31ClN6O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Balapiravir hydrochlorideBalapiravir hydrochloride (Ro 4588161 hydrochloride; R1626 hydrochloride) is an orally active prodrug of a nucleoside analogue inhibitor of the RNA-dependent RNA polymerase (RdRp) of HCV (R1479; 4'-Azidocytidine). Balapiravir hydrochloride has anti-HCV activity[1][2][3]. |
| Name | [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2-azido-3,4-bis(2-methylpropanoyloxy)oxolan-2-yl]methyl 2-methylpropanoate,hydrochloride |
|---|---|
| Synonym | More Synonyms |
| Description | Balapiravir hydrochloride (Ro 4588161 hydrochloride; R1626 hydrochloride) is an orally active prodrug of a nucleoside analogue inhibitor of the RNA-dependent RNA polymerase (RdRp) of HCV (R1479; 4'-Azidocytidine). Balapiravir hydrochloride has anti-HCV activity[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | After oral dosing of the CD-1 mice with 28.1 mg/kg of balapiravir (Ro 4588161 hydrochloride; R1626 hydrochloride), R1479 reaches a Cmax and a minimum concentration in plasma (Cmin) of 24.38 μM and 6.34 μM, respectively, at 2 h and 24 h postdosing[3]. |
| References |
| Molecular Formula | C21H31ClN6O8 |
|---|---|
| Molecular Weight | 530.95900 |
| Exact Mass | 530.18900 |
| PSA | 199.78000 |
| LogP | 2.29286 |
| Balapiravir hydrochloride |